Company news
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) news
Sun Pharmaceutical Industries Limited news releases on 6ix. Latest, Jun 11, 2025: Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun…
Press releases — page 2
Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.
June 11, 2025
Press Release Jun 03 2025
June 3, 2025
Press Release May 30 2025
May 30, 2025
Press Release May 16 2025
May 16, 2025
Press Release May 12 2025
May 12, 2025
Press Release May 08 2025
May 8, 2025
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
April 25, 2025
Press Release Apr 24 2025
April 24, 2025
Sun Pharmaceutical Industries Limited Press Release Apr 24 2025
April 23, 2025
Press Release Apr 07 2025
April 7, 2025
Sun Pharmaceutical Industries Limited Press Release Apr 07 2025
April 6, 2025
Press Release Feb 17 2025
February 17, 2025
Press Release Feb 04 2025
February 4, 2025
Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
October 28, 2024
Press Release Oct 25 2024
October 25, 2024
Press Release Oct 15 2024
October 15, 2024
Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUN
October 2, 2024
Press Release Oct 01 2024
October 1, 2024
Press Release Sep 26 2024
September 26, 2024
Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
September 9, 2024
Press Release Sep 06 2024
September 6, 2024
Press Release Aug 23 2024
August 23, 2024
Press Release Jul 26 2024
July 26, 2024
Sun Pharmaceutical Industries Limited Press Release Jul 26 2024
July 25, 2024
Press Release Jul 16 2024
July 16, 2024
Press Release Jul 04 2024
July 4, 2024
Press Release Jun 24 2024
June 24, 2024
Press Release Jun 22 2024
June 22, 2024
Press Release Jun 21 2024
June 21, 2024
Sun Pharmaceutical Industries Limited Press Release Jun 21 2024
June 20, 2024
Sun Pharma - Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis
June 17, 2024
Press Release Jun 14 2024
June 14, 2024
Press Release Jun 04 2024
June 4, 2024
Press Release May 31 2024
May 31, 2024
Press Release May 23 2024
May 23, 2024
Press Release Mar 19 2024
March 19, 2024
Sun Pharmaceutical Industries Limited Press Release Mar 19 2024
March 18, 2024
Press Release Feb 12 2024
February 12, 2024
Sun Pharmaceutical Industries Limited Press Release Feb 12 2024
February 11, 2024
Press Release Jan 31 2024
January 31, 2024
Press Release Jan 17 2024
January 17, 2024
Press Release Nov 01 2023
November 1, 2023
Press Release Oct 30 2023
October 30, 2023
Press Release Oct 16 2023
October 16, 2023
Press Release Oct 12 2023
October 12, 2023
Press Release Oct 06 2023
October 6, 2023
Sun Pharmaceutical Industries Limited Press Release Oct 06 2023
October 5, 2023
Press Release Sep 27 2023
September 27, 2023
Press Release Sep 14 2023
September 14, 2023
Press Release Aug 03 2023
August 3, 2023